© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Muscarinic regulation of cardiac L-type Ca2+ current
Pediatric Cardiology, University of California at Los Angeles, School of Medicine, 675 C.E. Young Drive South, MRL Rm. 3754, Los Angeles, CA 90095, USA
* Tel.: +1-310-825-7105; fax: +1-310-825-7458 fchen@mednet.ucla.edu
Received 4 September 2000; accepted 7 September 2000
| The first 10% of the full text of this article appears below. |
See article by Klein et al. [1] (pages 367–374) in this issue.
| 1 Introduction |
|---|
As discussed by Klein and his colleagues in this issue of Cardiovascular Research [1], cGMP is an important intracellular second messenger of various extracellular stimuli regulating L-type Ca2+ current (ICa-L) in both normal and failing hearts. It has been postulated that muscarinic agonists such as carbachol (CCh) bind to muscarinic receptors to promote formation of an activated inhibitory G protein–guanosine triphosphate (Gi-GTP) complex. Upon GTP binding, the heterotrimeric G protein dissociates into two moieties, Gi
-GTP and Giβ
. Gi
inhibits adenylyl cyclase (AC) [2,3] and decreases cyclic AMP (cAMP) concentration and thereby inhibits cAMP-dependent protein kinase (PKA). The final result is the inhibition of the phosphorylation of effectors such as | 2 Role of cGMP and cGMP-dependent protein kinase |
|---|
| 3 Role of nitric oxide synthase |
|---|
| 4 Conclusion |
|---|